期刊文献+

哮喘完全控制时气道炎症状态 被引量:3

The state of airway inflammation under the complete control of asthma.
原文传递
导出
摘要 目的探讨哮喘完全控制时气道炎症状态。方法哮喘患者36例,均按获得最佳哮喘控制研究的方法进行治疗,并测定肺功能和诱导痰细胞学分类。结果治疗后完全控制组肺功能改善更加明显,与非完全控制组的差异具有显著性(P<0.05);诱导痰嗜酸性粒细胞明显下降,与治疗前的差异具有显著性(P<0.05),但2组间差异无显著性。结论哮喘达到完全控制时,肺功能改善明显,但气道炎症并没有得到完全控制,与非完全控制者类似,仍然需要继续治疗。 Objective To explore the state of airway inflammation under the complete control of asthma. Methods There were 36 cases of asthma that were treated by the method of the best control of asthma. Induced sputum and pulmonary function were detected. Results After treatment, the pulmonary function was more obviously improved in complete control group than in non-complete control group ( P 〈 0.05 ), and induced sputum eosinophils count was obviously decreased, with significant difference compared with that before treatment ( P 〈 0.05 ), but there was no significant difference between the two groups. Conclusion The pulmonary function is improved apparently when asthma has been completely controlled, but the airway inflammation has not been totally Controlled, which is the same as non-complete control group, so it needs further treatment.
出处 《中国综合临床》 北大核心 2006年第6期511-513,共3页 Clinical Medicine of China
基金 广东省医学科研基金(A2005351) 2004年度暨南大学临床学院科研培育基金(200415)
关键词 哮喘 诱导痰 气道炎症 Asthma Induced sputum Airway inflammation
  • 相关文献

参考文献11

  • 1Bateman ED,Boushey HA,Bousquet J,et al.Can guideline-defined asthma control be achieved? The gaining optimal asthma control study[J].Am J Respir Crit Care Med,2004,170(8):836-844.
  • 2中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗及教育和管理方案)[J].中华结核和呼吸杂志,2003,26(3):132-138. 被引量:3563
  • 3Brightling CE,Ward R,Goh KL,et al.Eosinophilic bronchitis is an important cause of chronic cough[J].Am J Respir Crit Care Med,1999,160(2):406-410.
  • 4陈萍,赵海涛,孙丽,林江涛,张洪玉,黄绍光,朱宝玉,殷凯生,郑劲平,许文兵,沈华浩,李强,钟南山.全球哮喘防治创议推荐糖皮质激素的半量吸入分级治疗支气管哮喘患者的疗效分析[J].中华结核和呼吸杂志,2005,28(7):458-463. 被引量:45
  • 5Masoli M,Weatherall M,Holt S,et al.Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma[J].Thorax,2005,60(9):730-734.
  • 6Pauwels RA,Pedersen S,Busse WW,et al.Early intervention with budesonide in mild persistent asthma:a randomised,double-blind trial[J].Lancet,2003,29;361(9 363):1 071-1 076.
  • 7Magnussen H,Hargreave FE.Noninvasive monitoring of airway inflammation[J].Eur Respir J,2000,16(1):1-2.
  • 8Jayaram L,Parameswaran K,Sears MR,et al.Induced sputum cell counts:their usefulness in clinical practice[J].Eur Respir J,2000,16(1):150-158.
  • 9Jatakanon A,Lim S,Barnes PJ.Changes in sputum eosinophils predict loss of asthma control[J].Am J Respir Crit Care Med,2000,161(1):64-72.
  • 10Chang AB,Harrhy VA,Simpson J,et al.Cough,airway inflammation,and mild asthma exacerbation[J].Archives of Disease in Childhood,2002,86(4):270-275.

二级参考文献9

  • 1WHO/NHLBI Workshop Report. Global initiative for asthma management and prevention: pocket guide for asthma management and prevention in children. Maryland: National Institute of Health, National Heart, Lung, and Blood Institute, 2002. 6-9.
  • 2Hogg JC,James AL,Pare PD. Evidence for inflammation in asthma. Am Rev Respir Dis, 1991,143:S39-S42.
  • 3Adams N,Bestall J,Jone PW. Inhaled fluticasone at different doses for chronic asthma. Cochrane Database Syst Rev,2002,(1):CD003534.
  • 4Adams N,Bestall J,Jones PW. Inhaled fluticasone proprionate for chronic asthma. Cochrane Database Syst Rev,2001,(3):CD003135.
  • 5Kamada AK, Szefler SJ, Martin KJ, et al. Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network. Am J Respir Crit Care Med, 1996,153(6 Pt 1):1739-1748.
  • 6Pauwels RA, Pedrson S, Busse WW, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet, 2003, 361:1071-1076.
  • 7Clark DJ, Grove A, Cargill RI, et al. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax, 1996, 51:262-266.
  • 8支气管哮喘防治指南[J].中华结核和呼吸杂志,1997,20(5):261-267. 被引量:2004
  • 9陈爱欢,陈荣昌,钟南山.哮喘儿童持续吸入低剂量糖皮质激素的全身性副作用[J].中华结核和呼吸杂志,2001,24(12):740-743. 被引量:36

共引文献3594

同被引文献23

  • 1温志红,农生洲,胡琼燕,杜华,农利平,陈芳.不同时期哮喘患儿Clara细胞分泌蛋白测定的临床意义[J].中国综合临床,2005,21(12):1141-1142. 被引量:2
  • 2戴勤.普米克联合免疫疗法控制儿童哮喘远期效果观察[J].中国医药,2006,1(12):757-758. 被引量:2
  • 3田伟千,傅诚章,朱敏敏,李海霞.雾化吸入氯胺酮对哮喘大鼠肺组织一氧化氮及一氧化氮合酶的影响[J].实用临床医药杂志,2007,11(1):16-20. 被引量:6
  • 4Kankaanranta H, Lindsay MA, Giernbycz MA, et al. Delayed eosinophil apoptosis in asthma. J Allergy Clin lmmunol,2000,106( 1 Pt 1 ) :77-83.
  • 5Toumoy KG, Kips JC, Pauwels RA. Counterbalancing of Th2-driven allergic airway inflammation by IL-12 does not require IL-10. J Allerain lmmunol,2001,107 ( 3 ) : 483-491.
  • 6Ohkawara Y, Lei XF, Stampfli MR, et al. Cytokine and eosinophil responses in the lung peripheral blood and bone marrow compartments in a murlne model of allergen incluced airways inflammation ]. Am J Respir Cell Mol Boil, 1997,16 ( 5 ):510-520.
  • 7Ven bever HP. Comparision between the in vitroeytokin productin of monouclear cells of young asthmatics with and without immunothyapy. Clin Exp Allergy, 1998,28 ( 8 ) :943-949.
  • 8Kirschvink N, Martin N, Fievez L, et al. Airway inflammation in admium-exposed rats is associated with pulmonary oxidative stress and emphysema [ J ]. Free Radic Res,2006,40 ( 3 ) :2.
  • 9Belda J, Giner J, Casan P, et al. Mild exacerbationsand eosinophilic inflammationin patients with stable, well-controlled asthma after 1 year of follow-up[ J]. Chest,2001,119 (4) 1011 - 1017.
  • 10Schroer KT, Gibson AM, Sivaprasad U, et al. Downregulation of glutathione S-transferase pi in asthma contributes to enhanced oxidative stress [J]. J Allergy Clin Immunol,2011,128 (3) :539- 548.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部